Press "Enter" to skip to content

Alpha-glucosidase Inhibitors Market Outlook 2019 | Shows Industry Overview, Size, Share, Remarkable Growth Factors, Types, and Applications Forecast to 2024

Alpha-glucosidase

The “Alpha-glucosidase Inhibitors Market” 2019 report provides market size (value and volume), market share, growth rate by types, applications, and combines both qualitative and quantitative methods to make micro and macro forecasts in different regions or countries. Alpha-glucosidase Inhibitors Market report also aims to provide useful and comprehensive insights into current market trends and future growth scenarios. Alpha-glucosidase Inhibitors market report contains information like SWOT analysis, business highlights, strength, weakness, threats and opportunities of industry.

Top Manufacturers of Alpha-glucosidase Inhibitors Market Are:

  • Bayer pharma
  • Takeda
  • Pfizer
  • Glenmark pharma
  • Sun pharma
  • Torrent
  • Unichem
  • Hexalag

    Get a Sample Copy of the Report – https://www.industryresearch.co/enquiry/request-sample/14245695

    Market Overview:

  • – The global alpha-glucosidase inhibitors market registered a revenue of 4069 USD million in 2018 and is expected to grow at a CAGR of 2% during the forecast period of 2019-2024.
  • – The growth of alpha-glucosidase inhibitors (AGIs) is moderate, as it is considered mostly as second-line monotherapy treatment of drugs or given in combination with other first-line therapy drugs.
  • – The primary driver for the growth is mostly in more carbohydrate consumption regions. China and India hold the highest market value, due to their high consumption of carbohydrates, followed by North America (Canada and the United States).

    Scope of the Report:

  • The Market is Segmented by Drugs and Geography – Growth, Trends, and Forecast (2019 – 2024)

    Alpha-glucosidase Inhibitors Market Report Answers the Following Questions:

    • What will the market size and the growth rate be in 2024?
    • What are the key factors driving the global Alpha-glucosidase Inhibitors market?
    • What are the key market trends impacting the growth of the global Alpha-glucosidase Inhibitors market?
    • What are the challenges to market growth?
    • Who are the key vendors in the global Alpha-glucosidase Inhibitors market?
    • What are the market opportunities and threats faced by the vendors in the global Alpha-glucosidase Inhibitors market?
    • Trending factors influencing the market shares of the relevant regions.
    • What are the key outcomes of the five forces analysis of the global Alpha-glucosidase Inhibitors market?

    For More Information or Query or Customization Before Buying, Visit at – https://www.industryresearch.co/enquiry/pre-order-enquiry/14245695

    Key Market Trends:

    Acarbose is the most widely prescribed drug of the other two drugs currently available.

    – Acarbose is the most widely prescribed of the three currently available (Acarbose, Miglitol, and Voglibose) alpha?glucosidase inhibitors and has been used in the management of hyperglycemia for years.
    – Acarbose acts non?systemically to slow down carbohydrate digestion and attenuates high levels of post?prandial plasma glucose (PPG) – an essential manifestation in the early course of type 2 diabetes mellitus (T2DM) and a critical target for achieving glycemic control.
    – Patients take these agents at the beginning of each main meal. AGIs do not cause hypoglycemic events or other life-threatening events, even at overdoses, and cause no weight gain.
    – Despite numerous studies showing beneficial effects of acarbose as a first?line, second?line, and third?line treatment option, prescribing of this drug varies worldwide, due to a perception that efficacy is limited in some ethnic and regional groups.
    – However, AGIs frequently cause loose stools and flatulence, when used at the recommended doses (i.e., usually 100 mg acarbose three times daily).
    – Since these effects are dose-related, it is advised to start the treatment with low doses and gradually increase it accordingly. The side effect of loose stools may be useful in a patient preoccupied with constipation.

    Asia-Pacific holds the highest market share in the alpha-glucosidase market.

    – The Asia-Pacific holds more than 50% of the market share in 2018. China is facing the largest diabetes epidemic in the world, with around 11% of its population suffering from metabolic illness, while nearly 36% are pre-diabetic.
    – In 2018, China held the largest share in the Asia-Pacific alpha-glucosidase market due to the large patient pool and high prevalence rate in the country.

    Market Dynamics: –

    • Drivers: (Developing regions and growing markets)
    • Limitations: (Regional, Key Player facing Issues, Future Barriers for growth)
    • Opportunities: (Regional, Growth Rate, Competitive, Consumption)

    The report provides key statistics on the market status of the Alpha-glucosidase Inhibitors Market manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the Alpha-glucosidase Inhibitors .

    Purchase this Report (Price 5000 USD for single user license) – https://www.industryresearch.co/purchase/14245695

    Report Objectives:

    • Analyzing the size of the Alpha-glucosidase Inhibitors market on the basis of value and volume.
    • Accurately calculating the market segments, consumption, and other dynamic factors of different sections of the global Alpha-glucosidase Inhibitors market.
    • Determining the key dynamics of the Alpha-glucosidase Inhibitors market.
    • Highlighting significant trends of the Alpha-glucosidase Inhibitors market in terms of manufacture, revenue, and sales.
    • Deeply summarizing top players of the Alpha-glucosidase Inhibitors market and showing how they compete in the industry.
    • Studying industry processes and costs, product pricing, and various trends related to them.
    • Displaying the performance of different regions and countries in the global Alpha-glucosidase Inhibitors market.

    Detailed TOC of Alpha-glucosidase Inhibitors Market Report 2019-2024:

    1 INTRODUCTION
    1.1 Study Deliverables
    1.2 Study Assumptions
    1.3 Scope of the Study

    2 RESEARCH METHODOLOGY

    3 EXECUTIVE SUMMARY

    4 MARKET DYNAMICS
    4.1 Market Overview
    4.2 Drivers
    4.3 Restraints
    4.4 Porter’s Five Forces Analysis
    4.4.1 Bargaining Power of Suppliers
    4.4.2 Bargaining Power of Consumers
    4.4.3 Threat of New Entrants
    4.4.4 Threat of Substitute Products and Services
    4.4.5 Intensity of Competitive Rivalry

    5 MARKET SEGMENTATION
    5.1 Drug
    5.1.1 Alpha-glucosidase Inhibitors (Value and Volume 2012-2024)
    5.1.1.1 Alpha-glucosidase Inhibitors
    5.2 Geography
    5.2.1 North America
    5.2.1.1 United States (Value and Volume 2012-2024)
    5.2.1.2 Canada (Value and Volume 2012-2024)
    5.2.1.3 Rest of North America (Value and Volume 2012-2024)
    5.2.2 Europe
    5.2.2.1 France (Value and Volume 2012-2024)
    5.2.2.2 Germany (Value and Volume 2012-2024)
    5.2.2.3 Italy (Value and Volume 2012-2024)
    5.2.2.4 Spain (Value and Volume 2012-2024)
    5.2.2.5 United Kingdom (Value and Volume 2012-2024)
    5.2.2.6 Russia (Value and Volume 2012-2024)
    5.2.2.7 Rest of Europe (Value and Volume 2012-2024)
    5.2.3 Latin America
    5.2.3.1 Mexico (Value and Volume 2012-2024)
    5.2.3.2 Brazil (Value and Volume 2012-2024)
    5.2.3.3 Rest of Latin America (Value and Volume 2012-2024)
    5.2.4 Asia-Pacific
    5.2.4.1 Japan (Value and Volume 2012-2024)
    5.2.4.2 South Korea (Value and Volume 2012-2024)
    5.2.4.3 China (Value and Volume 2012-2024)
    5.2.4.4 India (Value and Volume 2012-2024)
    5.2.4.5 Australia (Value and Volume 2012-2024)
    5.2.4.6 Vietnam (Value and Volume 2012-2024)
    5.2.4.7 Malaysia (Value and Volume 2012-2024)
    5.2.4.8 Indonesia (Value and Volume 2012-2024)
    5.2.4.9 Philippines (Value and Volume 2012-2024)
    5.2.4.10 Thailand (Value and Volume 2012-2024)
    5.2.4.11 Rest of Asia Pacific (Value and Volume 2012-2024)
    5.2.5 Middle East and Africa
    5.2.5.1 Saudi Arabia (Value and Volume 2012-2024)
    5.2.5.2 Iran (Value and Volume 2012-2024)
    5.2.5.3 Egypt (Value and Volume 2012-2024)
    5.2.5.4 Oman (Value and Volume 2012-2024)
    5.2.5.5 South Africa (Value and Volume 2012-2024)
    5.2.5.6 Rest of Middle and Africa (Value and Volume 2012-2024)

    6 MARKET INDICATORS
    6.1 Type-1 Diabetes population (2012-2024)
    6.2 Type-2 Diabetes population (2012-2024)

    7 COMPETITIVE LANDSCAPE
    7.1 Company Profiles
    7.1.1 Bayer pharma
    7.1.2 Takeda
    7.1.3 Pfizer
    7.1.4 Glenmark pharma
    7.1.5 Sun pharma
    7.1.6 Torrent
    7.1.7 Unichem
    7.1.8 Hexalag

    8 MARKET OPPORTUNITIES AND FUTURE TRENDS

     

    Contact Us:

    Name: Ajay More

    Phone: US +14242530807/ UK +44 20 3239 8187

    Email: [email protected]

    Our Other Reports:

    Glass Mat Market Size 2019 Analysis By Industry Share, Emerging Demands, Growth Rate, Recent & Future Trends, Opportunity, and Forecast To 2024

    Indoor Cycling Market 2019 Size, Global Trends, Comprehensive Research Study, Development Status, Opportunities, Future Plans, Competitive Landscape and Growth by Forecast 2026

    Forage Grass Market 2019 Global Industry Trends, Statistics, Competition Strategies, Revenue Analysis, Key Players, Regional Analysis by Forecast to 2025

    Nurse Call Systems Market 2019 Global Industry Trends, Size, Segments, Competitors Strategy, Regional Analysis, Review, Key Players Profile, Statistics and Growth to 2024 Analysis

  • Be First to Comment

    Leave a Reply

    Your email address will not be published. Required fields are marked *